Carcinoma: all 6,718 studies
Page 28 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.
- Sentinel NOSE Study: Prospective Registration Study on the Sentinel Node Procedure for Bulky Squamous Cell Carcinoma of the Nasal Vestibule.CompletedNCT05637307Not applicable
- A Phase II Clinical Study of Fruquintinib Combined With S-1 for Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT05636150Phase 2
- Training Health Care Professional in Detecting BCC on OCT Using E-learning and CUSUM-analysisCompletedNCT05634421
- Peripheral Blood Neoantigen Specific T Cells Predict the Efficacy of Immunotherapy for Esophageal Squamous Cell CarcinomaStatus unknownNCT05633641
- Lipiodol-TACE With Idarubicin Based On a Specific Emulsion Ratio for Hepatocellular CarcinomaStatus unknownNCT05631613
- A Patient Decision Aid for Patients With Superficial Basal Cell CarcinomaCompletedNCT05628714
- Adoptive Treatment of Advanced Hepatocellular Carcinoma With Allogeneic γδ-T CellsWithdrawnNCT05628545Phase 1/2
- Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard ChemotherapyStatus unknownNCT05627427Phase 2
- Development and Validation of a Deep Learning System for Nasopharyngeal Carcinoma Using Endoscopic ImagesStatus unknownNCT05627310
- Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal NeoplasmsActive, not recruitingNCT05623787Not applicable
- Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerActive, not recruitingNCT05620134Phase 1/2
- A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of RO7616789 in Advanced Small Cell Lung Cancer and Other Neuroendocrine CarcinomasCompletedNCT05619744Phase 1
- Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular CarcinomaStatus unknownNCT05617430Phase 2
- Camrelizumab Plus Docetaxel and Cisplatin in Recurrent or Metastatic Oral Squamous Cell Carcinoma PatientsStatus unknownNCT05611463Phase 2
- T1 Squamous Cell Carcinomas of the LipActive, not recruitingNCT05610293
- Structural Description of Skin Biopsies With Dynamic Full-field Optical Coherence Tomography on Suspected Basal Cell Carcinoma Lesions, a Pilot Study (DOCTOBA)CompletedNCT05608902
- Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCCWithdrawnNCT05608369Phase 2
- Surgery Versus Non-surgical Treatment for Esophageal Squamous Cell Carcinoma in Patients Older Than 70 YearsCompletedNCT05604950
- KAT-101 in Subjects With Hepatocellular Carcinoma (HCC)SuspendedNCT05603572Phase 1/2
- Tislelizumab With Chemotherapy or Radiation for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma (TINES)Status unknownNCT05603065Phase 4
- Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)Status unknownNCT05603013Phase 2
- A Study of Camrelizumab in Combination With Anlotinib in Subjects Advanced Ovarian Clear Cell CarcinomaStatus unknownNCT05600998Not applicable
- Preoperative Stereotactic Body Radiotherapy (SBRT) Followed by Hepatectomy for Centrally Located Hepatocellular Carcinoma: a Prospective, Single-center, Phase I StudyStatus unknownNCT05598060Not applicable
- A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 with Valganciclovir (VGCV) in Subjects with Hepatocellular CarcinomaActive, not recruitingNCT05595473Phase 1/2
- Expression of Programmed Death Ligand-1 (PD-L1) in Nasopharyngeal and Hyypopharyngeal CarcinomaStatus unknownNCT05595265
- Thyroid Dysfunction Induced by Anti-PD-1 Therapy in Patients With Advanced CarcinomaCompletedNCT05593744
- Safety and Efficacy of Radiation Plus TACE and Lenvatinib in Advanced HCC With PVTTWithdrawnNCT05592197Not applicable
- Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE)Active, not recruitingNCT05587374Phase 3
- HAIC+Lenvatinib+Tislelizumab vs D-TACE+Lenvatinib+Tislelizumab for Unresectable HCCStatus unknownNCT05582278Phase 2
- Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable CancersWithdrawnNCT05582031Phase 2
- Added Value of OCT for Diagnosing Recurrent BCC After Non-invasive TreatmentCompletedNCT05581342Not applicable
- PET / MR With PSMA for Diagnosis and Staging of Hepatocellular CarcinomaStatus unknownNCT05580835Not applicable
- Anatomical Radiofrequency Ablation for Small Hepatocellular CarcinomaStatus unknownNCT05580224Not applicable
- Algorithm for Cervix Carcinoma Screening in CZ Using the Detection of HPV DNA and CINtec PlusCompletedNCT05578833
- AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING)Status unknownNCT05578430Phase 2
- Efficacy and Safety of Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous Cell CarcinomaStatus unknownNCT05578170
- Immunohistochemical Expression of Epithelial Cell Adhesion Molecule (EpCAM) in Epithelial Ovarian CarcinomaStatus unknownNCT05576519
- A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal CarcinomaActive, not recruitingNCT05576272Phase 2/3
- Clinical Study for Combined Analysis of CTC and Exosomes on Predicting the Efficacy of Immunotherapy in Patients With Hepatocellular CarcinomaStatus unknownNCT05575622
- Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline TherapyWithdrawnNCT05574504Phase 2
- Vitamin-D Receptor in Laryngeal Squamous Cell CarcinomaStatus unknownNCT05568641
- Efficacy and Safety of Sitravatinib Plus Tislelizumab or Placebo Plus Tislelizumab Versus Placebo as Adjuvant Treatment in Participants With Hepatocellular CarcinomaWithdrawnNCT05564338Phase 3
- Identification of Breath Biomarkers in Esophageal CancerCompletedNCT05557955
- A Real World Study of Regogfinib in HCCStatus unknownNCT05557656
- TACE Combined With Lenvatinib and MWA in the Treatment of Locally Advanced Large Hepatocellular CarcinomaStatus unknownNCT05555316Phase 2
- SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaStatus unknownNCT05552807Phase 1
- Envafolimab Combined With Chemotherapy in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell CarcinomaStatus unknownNCT05552651Phase 2
- Development of Intelligent Model for Radioactive Brain Damage of Nasopharyngeal Carcinoma Based on Radio-metabolomicsStatus unknownNCT05547971
- A Nomogram to Predict Major Postoperative Complications After Cytoreductive Surgery and HIPEC Based on Pre and Peroperative Criteria: Which Patient Require Intensive Monitoring?CompletedNCT05547568
- Research on Effectiveness and Safety of the Treatment, Hyperthermic Intraperitoneal Chemotherapy Combined With Tislelizumab and Targeted Therapy, That is Used for High-risk Hepatocellular Carcinoma After R0 ResectionActive, not recruitingNCT05546619Not applicable
- Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of RecurrenceStatus unknownNCT05545124Phase 2
- Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCCStatus unknownNCT05544253Phase 2/3
- Predicting Response to Systemic Therapies for Hepatocellular Carcinoma(HCC)Status unknownNCT05543304
- Pembrolizumab Plus CRT Followed by Surgery in Upper ESCCStatus unknownNCT05541445Phase 1/2
- Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal CarcinomatosisStatus unknownNCT05541146Phase 2
- Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast CancerWithdrawnNCT05539365Phase 2
- Safety and Efficacy of IPM001 in Patients With Advanced Hepatocellular CarcinomaStatus unknownNCT05536427Phase 1
- TACE-HAIC Combined With TKIs and Immunotherapy Versus TACE Alone for Hepatocellular Carcinoma With PVTTCompletedNCT05535998
- Phase 2 Study of Neoadjuvant SAR444245 Plus Cemiplimab in HPV Related Oropharynx Squamous Cell CarcinomaWithdrawnNCT05535023Phase 2
- Radiotherapy + Sintilimab + Bevacizumab Biosimilar for uHCC With PVTTStatus unknownNCT05530785Not applicable
- Induction Modified TPF Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and NeckActive, not recruitingNCT05527782Phase 2
- AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCCStatus unknownNCT05522894Phase 2
- PSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell CarcinomasCompletedNCT05522257Not applicable
- PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II TrialActive, not recruitingNCT05520814Phase 2
- Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002)Active, not recruitingNCT05520619Phase 2
- Short-term Psychodynamic Psychotherapy in Serious Physical IllnessCompletedNCT05520281Not applicable
- Pembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC)WithdrawnNCT05518032Phase 2
- Gemcitabine With Oxaliplatin (GEMOX) in Patients With Advanced Hepatocellular Carcinoma After Failure of Sorafenib TreatmentCompletedNCT05517239Phase 2
- Neoadjuvant Chemotherapy, Tislelizumab With Afatinib for HNSCCCompletedNCT05516589Phase 2
- Phase II Clinical Study to Compare the Efficacy and Safety of HLX07 + Serplulimab +Chemotherapy Versus Placebo + Serplulimab + Chemotherapy in First-Line Treatment of Patients With Recurrent or Metastatic NPCActive, not recruitingNCT05513573Phase 2
- A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After ChemoradiationWithdrawnNCT05512767Not applicable
- Digoxin for the Reinduction of Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid CarcinomaCompletedNCT05507775Not applicable
- Low-dose Radiotherapy and Neoadjuvant Chemotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal CarcinomaStatus unknownNCT05503914Not applicable
- A Proposed Tetra-modal Treatment Protocol for Muscle Invasive Urothelial Carcinoma of the Urinary BladderStatus unknownNCT05503563
- 68Ga-FAPI PET/CT for the Detection of Adenoid Cystic Carcinoma(ACC)Status unknownNCT05499936Not applicable
- Ablation of Hepatocellular Carcinoma: a Nationwide StudyCompletedNCT05498779
- A Phase 1/2 Study to Evaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association with the MYC OncogeneTerminatedNCT05497453Phase 1/2
- A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder CancerWithdrawnNCT05496192Phase 2
- HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCCStatus unknownNCT05493332Phase 2
- Outcome of Hepatocellular Carcinoma Patients With Portal Vein Thrombosis After Trans-Arterial Chemo EmbolizationStatus unknownNCT05491889
- Serum Levels of Some Trace Elements in Hepatocellular Carcinoma PatientsStatus unknownNCT05488587
- Oncological and Functional Outcomes of Laparoscopic Partial Nephrectomy in Renal Cell Carcinoma Stages T1 Versus T2a: Prospective Comparative Study.Status unknownNCT05486871Not applicable
- Neoadjuvant Therapy of Pembrolizumab Plus Lenvatinib in Advanced RCCCompletedNCT05485896Phase 2
- Selected De-escalation Radiotherapy for Postoperative Head and Neck Squamous Cell CarcinomaStatus unknownNCT05476965Phase 2
- Neoadjuvant Therapy of Camrelizumab Combined With Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT05476380Phase 2
- TACE With Dicycloplatin(TP21) in Unresectable HCCStatus unknownNCT05472896Phase 3
- Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck CancerWithdrawnNCT05472506Phase 1
- Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell CarcinomaWithdrawnNCT05472220Phase 1
- Neoadjuvant Anti-PD1 in HCCCompletedNCT05471674Phase 2
- Tislelizumab in Combination With Chemotherapy for Conversion Therapy of Locally Nonresectable ESCCStatus unknownNCT05469061Phase 2
- Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)CompletedNCT05461430
- Reducing Excision Margins After Neoadjuvant Chemoimmunotherapy for HPV Negative Resectable Locally Advanced HNSCCActive, not recruitingNCT05459415Not applicable
- Postoperative Radiotherapy for Oral Squamous Cell Carcinoma After Neoadjuvant Therapy and SurgeryCompletedNCT05455632
- Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma With Twin Cooled-wet ElectrodesStatus unknownNCT05449860Not applicable
- A Prospective, Randomized, Controlled Clinical Study of BET Combined With Tympanostomy Tube Insertion in the Treatment of Intractable OME After Radiotherapy for NPCStatus unknownNCT05449184Not applicable
- Ezurpimtrostat Autophagy Inhibitor in Association With Atezolizumab-Bevacizumab in First Line Treatment of Unresectable Hepatocellular CarcinomaTerminatedNCT05448677Phase 2
- Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast CancerTerminatedNCT05447910
- A Study to Collect Pre-existing Data on the Administration of Cabozantinib in Participants With Advanced Renal Cell Carcinoma (aRCC) Who Initiated Cabozantinib in 2nd Line in a Real-life Clinical Setting in France.CompletedNCT05444933
- A Prospective, Single-arm Clinical Study of Pabrolizumab in Combination With Cisplatin + 5-FU for the Neoadjuvant Treatment of Unresectable, Advanced Squamous Carcinoma of the Temporal Bone Single-arm Clinical StudyStatus unknownNCT05444673Phase 4
- Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® SystemTerminatedNCT05437679